Depression News and Research

Latest Depression News and Research

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

5a-reductase inhibitors for male health problems can affect sexual health

A new study published in The Journal of Sexual Medicine reveals that, for the first time, 5a-reductase inhibitors commonly used to treat urinary problems in patients with benign prostatic hyperplasia (BPH) and found in popular medications to treat hair loss, can produce, persistent erectile dysfunction (ED), depression and loss of libido, even after the medication has been discontinued.

7 Mar 2011

FDA accepts Lundbeck's clobazam NDA for review

Lundbeck Inc. today announced the U.S. Food and Drug Administration has accepted for review a New Drug Application for the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome in patients two years and older.

5 Mar 2011

CCC's new pilot program to help couples deal with conflict is now available for Canadians

Calgary Counselling Centre launched a new pilot program in late October, the first of its kind in Canada, to help couples dealing with conflict, The Strengthening Families Program.

5 Mar 2011

Study finds variation in drinking patterns among men, women depending on neighborhood type

Men living in low-income neighbourhoods consume more than three times as many alcoholic drinks each week compared to women in these neighbourhoods, according to a study led by St. Michael's researcher Flora Matheson.

4 Mar 2011

How cancer impacts patients and their partners

Katarina Sjövall has studied partners of individuals with colorectal cancer, lung cancer, breast cancer or prostate cancer. The study shows that the number of diagnosed diseases among partners increased by 25 per cent after the cancer diagnosis.

4 Mar 2011

New study: Depression and anxiety may influence physical symptoms

Researchers have for decades hypothesized that negative emotions lead to inflated reports of common physical symptoms, like headaches or an upset stomach. But a new University of Iowa study suggests that two negative emotions -- depression and anxiety -- influence symptom reporting in different ways.

4 Mar 2011

New study provides fascinating insight into genetic basis of bipolar disorder

A new study provides fascinating insight into the genetic basis of bipolar disorder, a highly heritable mood disorder characterized by recurrent episodes of mania and depression.

3 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.

3 Mar 2011

Birth of healthy child does not resolve depression and anxiety in women who miscarry

The depression and anxiety experienced by many women after a miscarriage can continue for years, even after the birth of a healthy child, according to a study led by University of Rochester Medical Center researchers and published online today by the British Journal of Psychiatry.

3 Mar 2011

Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders

Omeros Corporation today announced that it has identified compounds that interact selectively with two orphan G protein-coupled receptors linked to pancreatic cancer and cognitive disorders.

3 Mar 2011

Cyberonics third quarter net sales increase 15.3% to $47.1 million

Cyberonics, Inc., a global leader in epilepsy management, today announced results for the quarter ended January 28, 2011.

2 Mar 2011

Study: Medication adherence alone may not benefit employees with chronic conditions

Medication adherence alone may not be enough to impact the productivity of employees with chronic conditions such as depression, diabetes, hypertension and coronary artery disease.

2 Mar 2011

Self-perception of the body linked with general self-esteem

Low self-esteem is associated with a greater risk of mental health problems such as eating disorders and depression. From a public health perspective, it is important for staff in various health-related professions to know about self-esteem. However, there is a vast difference between the research-based knowledge on self-esteem and the simplified popular psychology theories that are disseminated through books and motivational talks, reveals research from the University of Gothenburg.

2 Mar 2011

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

An experimental drug that targets a brain system that controls inflammation might help preserve neurological function in people who survive sudden cardiac arrest, new research suggests.

2 Mar 2011

Study: Happy people tend to live longer and experience better health

A review of more than 160 studies of human and animal subjects has found "clear and compelling evidence" that - all else being equal - happy people tend to live longer and experience better health than their unhappy peers.

1 Mar 2011

High blood pressure medications useful even in those without hypertension: Study

Researchers have studied existing evidence to suggest that people who have had a stroke or a heart attack might benefit from taking blood pressure medications, even if they do not have high blood. They noted that for every 1,000 people taking the drugs in clinical trials, on average 15 fewer died from heart disease than when the patients got dummy treatment. The study however could not explain the cause for this benefit. The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.

1 Mar 2011

Think positive for a healthy heart: Study

Researchers suggest that heart disease patients are more likely to survive if they have a positive outlook. The study was published Feb. 28 in the journal Archives of Internal Medicine.

1 Mar 2011

Depression News and Research

Latest Depression News and Research

Prevalence of bipolar disorder

5a-reductase inhibitors for male health problems can affect sexual health

FDA accepts Lundbeck's clobazam NDA for review

CCC's new pilot program to help couples deal with conflict is now available for Canadians

Study finds variation in drinking patterns among men, women depending on neighborhood type

How cancer impacts patients and their partners

New study: Depression and anxiety may influence physical symptoms

New study provides fascinating insight into genetic basis of bipolar disorder

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Birth of healthy child does not resolve depression and anxiety in women who miscarry

Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders

Cyberonics third quarter net sales increase 15.3% to $47.1 million

Study: Medication adherence alone may not benefit employees with chronic conditions

Self-perception of the body linked with general self-esteem

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

Study: Happy people tend to live longer and experience better health

High blood pressure medications useful even in those without hypertension: Study

Think positive for a healthy heart: Study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Depression News and Research

Latest Depression News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in